Powering Drug Development With Advanced AI Retrosynthetic Analysis Tools
Source: Lonza
The complexity of small molecule APIs is on the rise, making their synthesis a formidable challenge. To address this, drug developers are seeking innovative solutions for efficient and reliable production. This article explores how Lonza's advanced retrosynthetic analysis services can accelerate and optimize the development of complex small molecule drugs.
Key Objectives:
- Understanding the evolving challenges in small molecule API synthesis
- Exploring the power of retrosynthetic analysis in drug development
- Demonstrating how cutting-edge retrosynthetic tools drive efficient and sophisticated drug creation
access the Article!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more